Natural killer cells in rejection and tolerance of solid organ allografts

Current Opinion in Organ Transplantation

Volumn 16, Issue 1, 2011, Pages 47-53

  Benichou, Gilles ^a   Yamada, Yohei ^a   Aoyama, Akihiro ^a   Madsen, Joren C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

chronic allograft vasculopathy; innate immunity; NK cells; solid organ transplantation; tolerance; transplant; transplant rejection

Indexed keywords

CHEMOKINE; CXCL1 CHEMOKINE; FRACTALKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR;

ADAPTIVE IMMUNITY; ALLOIMMUNITY; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELL KILLING; CELL SUBPOPULATION; CHRONIC GRAFT REJECTION; CYTOKINE RELEASE; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; NATURAL KILLER CELL; NONHUMAN; ORGAN TRANSPLANTATION; REGULATORY T LYMPHOCYTE; TARGET CELL; TH1 CELL; TH2 CELL; TRANSPLANTATION TOLERANCE;

ANIMALS; GRAFT REJECTION; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, NATURAL KILLER CELL; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 78751620387     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32834254cf     Document Type: Article

References (84)

1. Hamerman JA, Ogasawara K, Lanier LL. NK cells in innate immunity. Curr Opin Immunol 2005; 17:29-35.
2. Lanier LL. NK cell recognition. Annu Rev Immunol 2005; 23:225-274.
3. Yokoyama WM. The search for the missing missing-self receptor on natural killer cells. Scand J Immunol 2002; 55:233-237.
4. Yokoyama WM, Kim S. How do natural killer cells find self to achieve tolerance? Immunity 2006; 24:249-257.
5. Yokoyama WM, Kim S, French AR. The dynamic life of natural killer cells. Annu Rev Immunol 2004; 22:405-429.
6. Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285:727-729.
7. Diefenbach A, Jensen ER, Jamieson AM, Raulet DH. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 2001; 413:165-171.
8. Mandelboim O, Lieberman N, Lev M, et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001; 409:1055-1060.
9. Karre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2- deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986; 319:675-678.
10. Ljunggren HG, Karre K. In search of the missing self:MHCmolecules and NK cell recognition. Immunol Today 1990; 11:237-244.
11. Ljunggren HG, Sturmhofel K, Wolpert E, et al. Transfection of beta 2- microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants. J Immunol 1990; 145:380-386.
12. Biron CA, Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol 2001; 13:458-464.
13. Kiessling R, Klein E, Pross H, Wigzell H. Natural killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 1975; 5:117-121.
14. Kiessling R, Klein E, Wigzell H. Natural killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975; 5:112-117.
15. Karlhofer FM, Ribaudo RK, Yokoyama WM. MHC class I alloantigen specificity of Ly-49 IL-2-activated natural killer cells. Nature 1992; 358: 66-70.
16. Karlhofer FM, Ribaudo RK, Yokoyama WM. MHC class I alloantigen specificity of Ly-49 IL-2-activated natural killer cells. Nature 1992; 358: 66-70 [J Immunol 2006; 177:5761-5765].
17. Manilay JO, Sykes M. Natural killer cells and their role in graft rejection. Curr Opin Immunol 1998; 10:532-538.
18. Heidecke CD, Araujo JL, Kupiec-Weglinski JW, et al. Lack of evidence for an active role for natural killer cells in acute rejection of organ allografts. Transplantation 1985; 40:441-444.
19. Markus PM, van den Brink M, Cai X, et al. Effect of selective depletion of natural killer cells on allograft rejection. Transplant Proc 1991; 23:178-179.
20. Shelton MW, Walp LA, Basler JT, et al. Mediation of skin allograft rejection in scid mice by CD4 and CD8 T cells. Transplantation 1992; 54:278-286.
21. Kitchens WH, Uehara S, Chase CM, et al. The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation 2006; 81:811-817.
22. van der Touw W, Bromberg JS. Natural killer cells and the immune response in solid organ transplantation. Am J Transplant 2010; 10:1354-1358.
23. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferongamma. Annu Rev Immunol 1997; 15:749-795.
24. Martin-Fontecha A, Thomsen LL, Brett S, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004; 5:1260-1265.
25. Yoshida O, Akbar F, Miyake T, et al. Impaired dendritic cell functions because of depletion of natural killer cells disrupt antigen-specific immune responses in mice: restoration of adaptive immunity in natural killer-depleted mice by antigen-pulsed dendritic cell. Clin Exp Immunol 2008; 152:174-181.
26. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature 2009; 457:557-561.
27. Laffont S, Seillet C, Ortaldo J, et al. Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells. Blood 2008; 112:661-671.
28. Yu G, Xu X, Vu MD, et al. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 2006; 203:1851-1858.
29. Maroof A, Beattie L, Zubairi S, et al. Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function. Immunity 2008; 29:295-305.
30. Zecher D, Li Q, Oberbarnscheidt MH, et al. NK cells delay allograft rejection in lymphopenic hosts by downregulating the homeostatic proliferation of CD8 T cells. J Immunol 184:6649-6657.
31. Bingaman AW, Ha J, Waitze SY, et al. Vigorous allograft rejection in the absence of danger. J Immunol 2000; 164:3065-3071.
32. Zijlstra M, Auchincloss H Jr, Loring JM, et al. Skin graft rejection by beta 2- microglobulin-deficient mice. J Exp Med 1992; 175:885-893.
33. McNerney ME, Lee KM, Zhou P, et al. Role of natural killer cell subsets in cardiac allograft rejection. Am J Transplant 2006; 6:505-513.
34. Oertel M, Berr F, Schroder S, et al. Acute rejection of hepatic allografts from HLA-DR13 (Allele DRB1(-)1301)-positive donors. Liver Transpl 2000; 6:728-733.
35. Oertel M, Kohlhaw K, Diepolder HM, et al. Alloreactivity of natural killer cells in allogeneic liver transplantation. Transplantation 2001; 72:116-122.
36. Dresske B, Zhu X, Herwartz C, et al. The time pattern of organ infiltration and distribution of natural killer cells and macrophages in the course of acute graft rejection after allogeneic heart transplantation in the rat. Transplant Proc 1997; 29:1715-1716.
37. Young NT. Immunobiology of natural killer lymphocytes in transplantation. Transplantation 2004; 78:1-6.
38. Lanier LL. Activating and inhibitory NK cell receptors. Adv Exp Med Biol 1998; 452:13-18.
39. Lanier LL. NK cell receptors. Annu Rev Immunol 1998; 16:359-393.
40. Long EO, Wagtmann N. Natural killer cell receptors. Curr Opin Immunol 1997; 9:344-350.
41. Renard V, Cambiaggi A, Vely F, et al. Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes. Immunol Rev 1997; 155:205-221.
42. Biron CA, Nguyen KB, Pien GC, et al. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999; 17:189-220.
43. Smyth MJ, Cretney E, Takeda K, et al. Tumor necrosis factor-related apoptosis- inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med 2001; 193:661-670.
44. Takeda K, Hayakawa Y, Smyth MJ, et al. Involvement of tumor necrosis factorrelated apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 2001; 7:94-100. (Pubitemid 32095647)
45. Trapani JA, Smyth MJ. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002; 2:735-747.
46. Feng L, Ke N, Ye Z, et al. Expression of NKG2D and its ligand in mouse heart allografts may have a role in acute rejection. Transplant Proc 2009; 41:4332-4339.
47. Hankey KG, Drachenberg CB, Papadimitriou JC, et al. MIC expression in renal and pancreatic allografts. Transplantation 2002; 73:304-306.
48. Suarez-Alvarez B, Alonso-Arias R, Bravo-Mendoza C, et al. Identification of epitopes and immunodominant regions on the MICA protein defined by alloantibodies from kidney transplant patients. Transplantation 2009; 88:S68-77.
49. Suarez-Alvarez B, Lopez-Vazquez A, Baltar JM, et al. Potential role of NKG2D and its ligands in organ transplantation: new target for immunointervention. Am J Transplant 2009; 9:251-257.
50. Benichou G, Takizawa PA, Olson CA, et al. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992; 175:305-308.
51. Benichou G, Valujskikh A, Heeger PS. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 1999; 162: 352-358.
52. Lee RS, Yamada K, Houser SL, et al. Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy. Proc Natl Acad Sci U S A 2001; 98:3276-3281. (Pubitemid 32220836)
53. Sayegh MH, Carpenter CB. Role of indirect allorecognition in allograft rejection. Int Rev Immunol 1996; 13:221-229.
54. Suciu-Foca N, Liu Z, Colovai AI, et al. Indirect T-cell recognition in human allograft rejection. Transplant Proc 1997; 29:1012-1013.
55. Kondo T,Morita K, Watarai Y, et al. Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells. Transplantation 2000; 69:969-977.
56. Obara H, Nagasaki K, Hsieh CL, et al. IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses. Am J Transplant 2005; 5:2094-2103.
57. Szot GL, Zhou P, Rulifson I, et al. Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice. Am J Transplant 2001; 1:38-46.
58. Maier S, Tertilt C, Chambron N, et al. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Nat Med 2001; 7:557-562.
59. Kim J, Chang CK, Hayden T, et al. The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection. J Immunol 2007; 179:6416-6420.
60. Kroemer A, Xiao X, Degauque N, et al. The innate NK cells, allograft rejection, and a key role for IL-15. J Immunol 2008; 180:7818-7826.
61. Hayry P. Molecular pathology of acute and chronic rejection. Transplant Proc 1994; 26:3280-3284.
62. Hayry P, Isoniemi H, Yilmaz S, et al. Chronic allograft rejection. Immunol Rev 1993; 134:33-81.
63. Hosenpud JD, Mauck KA, Hogan KB. Cardiac allograft vasculopathy: IgM antibody responses to donor-specific vascular endothelium. Transplantation 1997; 63:1602-1606.
64. Russell ME. Graft arteriosclerosis: molecular features of macrophage activation. Transplant Proc 1997; 29:2542-2543.
65. Russell ME, Hancock WW, Akalin E, et al. Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J Clin Invest 1996; 97:833-838.
66. Russell PS, Chase CM, Sykes M, et al. Tolerance, mixed chimerism, and chronic transplant arteriopathy. J Immunol 2001; 167:5731-5740.
67. Uehara S, Chase CM, Colvin RB, et al. Further evidence that NK cells may contribute to the development of cardiac allograft vasculopathy. Transplant Proc 2005; 37:70-71.
68. Uehara S, Chase CM, Kitchens WH, et al. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J Immunol 2005; 175:3424-3430.
69. Rolls HK, Kishimoto K, Dong VM, et al. T-cell response to cardiac myosin persists in the absence of an alloimmune response in recipients with chronic cardiac allograft rejection. Transplantation 2002; 74:1053-1057.
70. Fedoseyeva EV, Kishimoto K, Rolls HK, et al. Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants. J Immunol 2002; 169:1168-1174.
71. Fedoseyeva EV, Zhang F, Orr PL, et al. De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J Immunol 1999; 162:6836-6842.
72. Benichou G, Alessandrini A, Charrad RS, Wilkes DS. Induction of autoimmunity after allotransplantation. Front Biosci 2007; 12:4362-4369.
73. Boisgerault F, Anosova NG, Tam RC, et al. Induction of T-cell response to cryptic MHC determinants during allograft rejection. Hum Immunol 2000; 61:1352-1362.
74. Benichou G, Takizawa PA, Ho PT, et al. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides. J Exp Med 1990; 172:1341-1346.
75. Benichou G, Tam RC, Orr PI, et al. Self determinant selection and acquisition of the autoimmune T cell repertoire. Immunol Res 1996; 15: 234-245.
76. Sercarz EE, Lehmann PV, Ametani A, et al. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993; 11:729-766.
77. Beilke JN, Kuhl NR, Van Kaer L, Gill RG. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med 2005; 11:1059-1065.
78. Goldstein DR, Thomas JM, Kirklin JK, George JF. An essential role for natural killer cells in augmentation of allograft survival mediated by donor spleen cells. Transplantation 2001; 72:954-956.
79. Haspot F, Seveno C, Dugast AS, et al. Anti-CD28 antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR class II B7 regulatory cells. Am J Transplant 2005; 5:2339-2348.
80. Eriksson M, Meadows SK, Wira CR, Sentman CL. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta. J Leukoc Biol 2004; 76:667-675.
81. Sonoda KH, Faunce DE, Taniguchi M, et al. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol 2001; 166:42-50.
82. Sonoda KH, Stein-Streilein J. Ocular immune privilege and CD1d-reactive natural killer T cells. Cornea 2002; 21:S33-S38.
83. Stein-Streilein J, Sonoda KH, Faunce D, Zhang-Hoover J. Regulation of adaptive immune responses by innate cells expressing NK markers and antigen-transporting macrophages. J Leukoc Biol 2000; 67:488-494.
84. Stein-Streilein J, Watte C. Cross talk among cells promoting anterior chamber- associated immune deviation. Chem Immunol Allergy 2007; 92:115-130.